| Trial ID: | L4214 |
| Source ID: | NCT02060916
|
| Associated Drug: |
Paz320
|
| Title: |
Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes
|
| Acronym: |
PAZ320
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Treated With Insulin
|
| Interventions: |
DRUG: PAZ320
|
| Outcome Measures: |
Primary: To evaluate the efficacy of the food supplement PAZ320 on post-prandial glucose excursion, 1 week | Secondary: Number of Subjects with Adverse Events as a Measure of Safety and Tolerability, 1 week
|
| Sponsor/Collaborators: |
Sponsor: Boston Therapeutics
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-03
|
| Completion Date: |
2011-08
|
| Results First Posted: |
|
| Last Update Posted: |
2014-02-13
|
| Locations: |
Dartmouth-Hitchcock Medical Center, Dartmouth, New Hampshire, 03755, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02060916
|
